The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mogilevets E.V.

Grodno State Medical University

Vorobey A.V.

Belarusian Medical Academy of Postgraduate Education

Garelik P.V.

Grodno State Medical University

Prognosis of bleeding recurrence after endoscopic sclerotherapy of esophageal varices

Authors:

Mogilevets E.V., Vorobey A.V., Garelik P.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2020;(10): 60‑67

Read: 4042 times


To cite this article:

Mogilevets EV, Vorobey AV, Garelik PV. Prognosis of bleeding recurrence after endoscopic sclerotherapy of esophageal varices. Pirogov Russian Journal of Surgery. 2020;(10):60‑67. (In Russ.)
https://doi.org/10.17116/hirurgia202010160

Recommended articles:
Effe­ctiveness of etiotropic therapy in achieving reco­mpensation of cirrhosis. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):68-77

References:

  1. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361:952-954.  https://doi.org/10.1016/S0140-6736(03)12778-X
  2. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65(1):310-335.  https://doi.org/10.1002/hep.28906
  3. Tayyem O, Bilal M, Samuel R, Merwat SK. Evaluation and management of variceal bleeding. Dis Mon. 2018;64(7):312-320.  https://doi.org/10.1016/j.disamonth.2018.02.001
  4. De Franchis, R. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology. 2010;53: 762-768.  https://doi.org/10.1016/j.jhep.2010.06.004
  5. Irisawa A, Saito A, Shibukawa G, Takagi T, Shishido H, Sakamoto H, Kasukawa R. Endoscopic recurrence of esophageal varices is associated with the specific EUS abnormalities: severe periesophageal collateral veins and large perforating veins. Gastrointest Endosc. 2001;53(1):77-84.  https://doi.org/10.1067/mge.2001.108479
  6. Bernard B, Cadranel J-F, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108:1828-1834. https://doi.org/10.1016/0016-5085(95)90146-9
  7. D’Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599-612.  https://doi.org/10.1053/jhep.2003.50385
  8. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs A K. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27:1207-1212. https://doi.org/10.1002/hep.510270504
  9. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, Marrero JM, Buceta E, Sánchez J, Castellot A, Peñate M, Cruz A, Peña E. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793-801.  https://doi.org/10.1002/hep.1840400408
  10. D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475-505.  https://doi.org/10.1055/s-2007-1007133
  11. Bolarin DM, Azinge EC. Biochemical markers, extracellular components in liver fibrosis and cirrhosis. Nig Q J Hosp Med. 2007;17(1):42-52. PMID:17688172 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.